Exceling at Accelerating in Rare Disease Drug Development

In this article, we discuss several challenges in rare disease drug development and why the need for innovation in this space is even more critical than for more common diseases.

Related Keywords

United States ,Americans , ,National Institutes Of Health ,Drug Administration ,National Institutes ,Orphan Drug Act ,Drug Evaluation ,Accelerating Rare ,Rare Disease Cures Accelerator Data ,Analytics Platform ,